Apimeds Pharmaceuticals US, Inc. (APUS) earnings
Quarterly results of Apimeds Pharmaceuticals US, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Apimeds Pharmaceuticals US, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Apimeds Pharmaceuticals US, Inc. reported revenue of - and a net loss of $20.2M.
Diluted earnings per share were -$11.77.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$20.2M | -$11.77 |
| Q1 FY2026 | - | - | -$35.1M | -$2.26 |
| Q4 FY2025 | - | - | -$1.2M | - |
| Q3 FY2025 | - | - | -$1.8M | -$0.14 |
| Q2 FY2025 | - | - | -$2.7M | -$2.57 |
| Q1 FY2025 | - | - | -$402.4K | -$0.05 |
| Q4 FY2024 | - | - | -$311.6K | - |
| Q3 FY2024 | - | - | -$332.5K | -$0.04 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is Apimeds Pharmaceuticals US, Inc.'s next earnings date?
Apimeds Pharmaceuticals US, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
Get an email when APUS reports
Follow APUS and we email you its next results the day they are filed, with the numbers explained.